CSNK1D and hepatocellular carcinoma: CRY2, casein kinase 1 delta (CSNK1D), f-box and leucine-rich repeat protein 21 (FBXL21), and PER1, for the prognosis of HCC and the prediction of immune infiltration sensitivity [164].